SCHEMBL4865780

SCHEMBL4865780

CCCC1=C[N]N=N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5004309 0.79
SCHEMBL3622155 0.69
SCHEMBL5007258 0.65
SCHEMBL2302116 0.61 NOS3 (0.33)
SCHEMBL10656026 0.61
SCHEMBL2764539 0.60
SCHEMBL2074486 0.59 HTR3A (0.35)
SCHEMBL5009239 0.55
SCHEMBL1424748 0.54
SCHEMBL7382635 0.52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110191709-A It can be used as the compound of indole amine 2,3-dioxygenase and/or tryptophan dioxygenase inhibitor 德州大学系统董事会 2019-08-30 CN disclosed
US-20080300135-A1 5-Alkyl-7-Amino-6-Heteroaryl-1,2,4-Triazolo[1,5-A]Pyrimidine Compounds and Their Use for Controlling Harmful Fungi BASF AKTIENGESELLSCHAFT (DE) 2008-12-04 US disclosed
US-7361743-B2 Such as 5-propyl-azepane-2-carboxylic acid [2-chloro-1-(3,4,5-trihydroxy-6-methylsulfanyl-tetrahydro-pyran-2-yl)-propyl]-amide; for prevention and treatment of mycobacterial, mycoplasmal or chlamydia infection; microbiocides PFIZER INC (US) 2008-04-22 US disclosed
EP-1814893-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY Vicuron Pharmaceuticals, Inc. (US) 2007-08-08 EP disclosed
WO-2007006724-A1 5-ALKYL-7-AMINO-6-HETEROARYL-1,2,4-TRIAZOLO[1,5-A]PYRIMIDINE COMPOUNDS AND USE THEREOF FOR THE PREVENTION OF FUNGAL PESTS BASF AKTIENGESELLSCHAFT (DE) 2007-01-18 WO disclosed
US-20060148722-A1 Novel lincomycin derivatives possessing antibacterial activity VICURON PHARMACEUTICALS INC. (US) 2006-07-06 US disclosed
WO-2006055070-A2 NOVEL LINCOMYCIN DERIVATIVES POSSESSING ANTIBACTERIAL ACTIVITY VICURON PHARMACEUTICALS INC. (US) 2006-05-26 WO disclosed